Ainslie Little has focused on patent strategy and protection of stem cell technologies for almost a decade.
At BlueRock Therapeutics, Ainslie is responsible for developing and executing intellectual property strategies, building and managing global patent and trademark portfolios, conducting due diligence to support business objectives, and developing and implementing IP policies and education programs.
Before joining BlueRock Therapeutics, Ainslie practiced at leading law firms in Canada and the United States where she focused on drafting and prosecuting patent applications and advising on patentability, validity, infringement and freedom-to-operate matters.
Ainslie is a registered patent agent in the United States and Canada. She holds a B.Sc. from the University of Guelph and a Ph.D. in microbiology from the University of Wisconsin-Madison.